Summary
Twenty-two Italian HIV-infected patients developed leishmaniasis, clinically manifested as visceral (13 cases), cutaneous (2 cases) and disseminated disease (7 cases). Twenty were males and two females (mean age: 32.8 years) with a mean CD4+ cell count of 46.8/μl at diagnosis; risk factors were intravenous drug use (17 patients) and sexual behaviour (two bisexual, two homosexual, one heterosexual). All but one patient lived or travelled in hypoendemic Italian regions and other Mediterranean countries. Apart from the two patients with cutaneous leishmaniasis, the clinico-pathological and biological spectrum of the infection was often atypical, especially in patients with disseminated disease. The diagnosis was routinely made by direct recovery of parasites in biological specimens, mainly in bone marrow aspirate, whereas serology was negative or borderline in most of the patients. Among 17in vitro isolates,Leishmania infantum was the only species involved with previously undescribed isoenzyme patterns in two cases. Treatment with antimonials and other drugs showed only temporary clinical improvement in some patients. Relapses were the rule. Leishmaniasis confirms itself as an opportunistic infection in HIV-positive persons. Secondary chemoprophylaxis should be considered in cases of relapsing disease.
Similar content being viewed by others
References
Alvar, J., Cañavate, C., Gutiérrez-Solar, B., Jiménez, M., Laguna, F., Lopez-Vélez, R., Molina, R., Moreno, J.:Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10 (1997) 298–319.
World Health Organization:Leishmania/HIV co-infection. Epidemiological analysis of 692 retrospective cases. Wkly. Epidemiol. Rec. 8 (1997) 49–54.
World Health Organization: Report on the consultative meeting onLeishmania/HIV co-infection [WHO/LEISH/95.35] WHO, Geneva (1995) 1–14.
Alvar, J.: Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol. Today 10 (1994) 160–163.
Tremblay, M., Olivier, M., Bernier, M.:Leishmania and the pathogenesis of HIV infection. Parasitol. Today 12 (1996) 257–261.
Person, R. D., de Queiros Sousa, A.: Clinical spectrum of leishmaniasis. Clin. Infect. Dis. 22 (1996) 1–13.
Condom, M. A., Clotet, B., Sirera, G., Milla, F., Foz, M.: Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 111 (1989) 767–768.
Pineda, J. A., Hernandez Quero, J., Gallardo, J. A., Lopez-Ruz, M. A., Martinez-Perez, M. A., Macias, J., Lissen, E.: Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 263–264.
Peters, B. S., Fish, D., Golden, R., Evans, D. A., Bryceson, A. D. M., Pinching, A. J.: Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Quart. J. Med. 283 (1990) 1101–1111.
Montalban, C., Calleja, J. L., Erice, A., Laguna, F., Clotet, B., Podzamczer, D., Cobo, J., Mallolas, J., Yebra, M., Gallego, A.: Visceral leishmaniasis in patients infected with human immunodeficiency virus. J. Infect. 21 (1990) 261–270.
Rosenthal, E., Merty, P., Poizot-Martin, I., Reynes, J., Pratlong, F., Lafeuillade, A., Jaubert, D., Boulet, D., Dereure, J., Gambarelli, F., Gastent, J. A., Dujardin, P., Dellamonica, P., Cassuto, J. P.: Visceral leishmaniasis and HIV-1 co-infection in Southern France. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 159–162.
Berman, J. D.: Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24 (1997) 684–703.
Gradoni, L., Bryceson, A., Desjeux, P.: Treatment of Mediterranean visceral leishmaniasis. Bull. World Health Organ. 73 (1995) 191–197.
Amela, C., Lopez-Gay, D., Alberdi, J. C., Castilla, J.: Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients. Eur. J. Epidemiol. 12 (1996) 91–92.
Herrera, E., Bosch, R. J., Fernandez, F., de Troya, M., Sanchez, P.: The presence and significance ofLeishmania in mucocutaneous biopsies from HIV+ patients with visceral leishmaniasis. Eur. J. Dermatol. 6 (1996) 501–504.
Gasser, I., Jaén, A., Gonzales, J., Ribera, E.: Diagnosis of visceral leishmaniasis in HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 967–968.
Gramiccia, M., Gradoni, L., Troiani, M.: HIV-Leishmania coinfection in Italy. Isoenzyme characterization ofLeishmania causing visceral leishmaniasis in HIV patients. Trans. R. Soc. Trop. Med. 86 (1992) 161–163.
Pratlong, F., Dedet, P., Marty, P., Portus, M., Deniau, M., Dereure, J., Abranches, P., Reynes, J., Martini, A., Lefebvre, M., Rioux, J. A.:Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of theLeishmania infantum complex. J. Infect. Dis. 172 (1995) 323–326.
Scaglia, M., Malfitano, A., Douville, H., Sacchi, P., Gatti, S., Gradoni, L., Gramiccia, M.: Dermonodular and visceral leishmaniasis due toLeishmania infantum with a new isoenzyme pattern: report of a case involving a patient with AIDS. Clin. Infect. Dis. 22 (1996) 376–377.
Pratlong, F., Reynes, J., Dereure, J., Baixench, M. T., Marchou, B., Lefebvre, M., Janbon, F.: Characterization ofLeishmania isolates from two AIDS patients originating from Valencia, Spain. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 705–706.
Jimenez, M. J., Laguna, F., de la Torre, F., Solis, F., Pratlong, F., Alvar, J.: NewLeishmania infantum zymodemes responsible for visceral leishmaniasis in patients co-infected with HIV in Spain. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 33.
Gradoni, L., Scalone, A., Gramiccia, M., Troiani, M.: Epidemiological surveillance of leishmaniasis in HIV-1 infected individuals in Italy. AIDS 10 (1996) 785–791.
Pérez-Molina, J. A., Lopez-Vélez, R., Montilla, P., Guerrero, A.: Pentamidine isothionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients. AIDS 10 (1996) 237–238.
Ribera, E., Ocaña, I., de Otero, J., Cortes, E., Gasser, I., Pahissa, A.: Prophylaxis of visceral leishmaniasis in human immunodeficiency virus infected patients. Am. J. Med. 100 (1996) 496–501.
Pérez-Molina, J. A., Lopez-Vélez, R., Guerrero, A.: Secondary prophylaxis for visceral leishmaniasis in HIV-infected individuals. Am. J. Med. 102 (1997) 132.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Agostoni, C., Dorigoni, N., Malfitano, A. et al. Mediterranean leishmaniasis in HIV-infected patients: Epidemiological, clinical, and diagnostic features of 22 cases. Infection 26, 93–99 (1998). https://doi.org/10.1007/BF02767767
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02767767